[Experimental models for the study of antiseptics]

Area of Science:

• Microbiology
• Dermatology
• Pharmacology

Context:

• In vitro determination of antiseptic bactericidal concentration is standardized, but in vivo measurement in humans is difficult due to variations in skin sampling and bacterial growth.
• Existing in vivo models using hologenic Hairless mice for skin sampling show promise but still suffer from inter-animal variability.
• Standardization is crucial for reliable comparison of antiseptic efficacy in real-world applications.

Purpose:

• To address the challenges in standardizing the in vivo evaluation of antiseptic bactericidal activity.
• To introduce and advocate for the use of monoxenic Hairless mice as a reproducible experimental model.
• To improve the consistency and comparability of antiseptic efficacy studies.

Summary:

• This study proposes using monoxenic Hairless mice, colonized with specific bacteria (Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa), to overcome variability in in vivo antiseptic testing.
• Experiments demonstrated consistent bacterial growth and minimal variation in microbial flora across individual animals over time.
• The monoxenic model provides a standardized and reproducible method for evaluating the bactericidal activity of antiseptics on skin.

Impact:

• This research provides a more reliable method for standardizing the evaluation of antiseptic bactericidal activity in vivo.
• The proposed model can lead to more accurate comparisons of antiseptic effectiveness, aiding in the development of better infection control strategies.
• Improved in vivo testing models will enhance the development and regulatory approval of effective antiseptic products.